阿片受体拮抗剂可减弱氯胺酮的抗抑郁效应
该研究在30例难治性抑郁症成人中开展双盲交叉试验,中期分析12例完成者发现,预先给予纳曲酮50 mg可显著减弱静脉氯胺酮0.5 mg/kg在输注后第1天和第3天的HAM-D评分下降,但不影响氯胺酮所致分离效应;因纳曲酮明显阻断抗抑郁效应而未阻断分离效应,试验在中期分析时终止。结论提示氯胺酮的急性抗抑郁效应需要阿片系统激活。
要点
- 纳曲酮预处理减弱氯胺酮在难治性抑郁症中的急性抗抑郁效应。
- 纳曲酮不影响氯胺酮所致分离效应,提示分离效应不由阿片系统介导。
- 中期分析显示效应差异后试验提前终止。
核心结论
- 氯胺酮的急性抗抑郁效应需要阿片系统激活。
- 氯胺酮的分离效应不由阿片系统介导,且在没有阿片效应时不足以产生急性抗抑郁效应。
研究设计与样本
- 拟纳入30例难治性抑郁症成人的双盲交叉研究,在14例受试后开展预设中期分析。
- 12例完成随机顺序的两种条件:安慰剂或纳曲酮50 mg预处理后静脉输注氯胺酮0.5 mg/kg。
主要发现
- 中期分析中,12例难治性抑郁症成人有7例在氯胺酮加安慰剂条件下于输注后第1天达到应答标准(HAM-D 17项评分下降≥50%)。
- 氯胺酮加纳曲酮条件下,受试者在输注后第1天和第3天的HAM-D 6项和17项评分下降显著低于氯胺酮加安慰剂条件。
- 对所有完成安慰剂和纳曲酮条件者的二次分析显示类似结果,且两种条件下氯胺酮所致分离无差异。
关键数值与推荐
- 应答定义为输注后第1天17项HAM-D评分下降≥50%。
- 纳曲酮剂量为50 mg,氯胺酮静脉剂量为0.5 mg/kg。
临床怎么用
- 解读氯胺酮抗抑郁机制时需考虑阿片系统激活的作用。
- 氯胺酮的分离效应不能作为急性抗抑郁效应的充分替代指标。
局限性
- 研究在中期分析时终止,样本量有限。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine whether opioid receptor antagonism prior to administration of intravenous ketamine attenuates its acute antidepressant or dissociative effects. METHOD: In a proposed double-blind crossover study of 30 adults with treatment-resistant depression, the authors performed a planned interim analysis after studying 14 participants, 12 of whom completed both conditions in randomized order: placebo or 50 mg of naltrexone preceding intravenous infusion of 0.5 mg/kg of ketamine. Response was defined as a reduction ≥50% in score on the 17-item Hamilton Depression Rating Scale (HAM-D) score on postinfusion day 1. RESULTS: In the interim analysis, seven of 12 adults with treatment-resistant depression met the response criterion during the ketamine plus placebo condition. Reductions in 6-item and 17-item HAM-D scores among participants in the ketamine plus naltrexone condition were significantly lower than those of participants in the ketamine plus placebo condition on postinfusion days 1 and 3. Secondary analysis of all participants who completed the placebo and naltrexone conditions, regardless of the robustness of response to ketamine, showed similar results. There were no differences in ketamine-induced dissociation between conditions. Because naltrexone dramatically blocked the antidepressant but not the dissociative effects of ketamine, the trial was halted at the interim analysis. CONCLUSIONS: The findings suggest that ketamine's acute antidepressant effect requires opioid system activation. The dissociative effects of ketamine are not mediated by the opioid system, and they do not appear sufficient without the opioid effect to produce the acute antidepressant effects of ketamine in adults with treatment-resistant depression.
引用
- Williams NR, Heifets BD, Blasey C, et al. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. Am J Psychiatry. 2018. PMID: 30153752. doi:10.1176/appi.ajp.2018.18020138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。